Log In
Print this Print this

pemetrexed RTD (EP-5101)

  Manage Alerts
Collapse Summary General Information
Company Eagle Pharmaceuticals Inc.
DescriptionReady-to-dilute, IV formulation of pemetrexed, an antifolate that inhibits thymidylate synthase, dihydrofolate reductase (DHFR) and glycinamide ribonucleotide formyltransferase (GARFT)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationNon-small cell lung cancer (NSCLC)
Indication DetailsTreat locally advanced or metastatic non-small cell lung cancer (NSCLC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today